RxDoctor Payments DataLook up a doctor →

Abigail Connell

Physician Assistant · Sparks, NVNPI 1801441530

Payments from drug & device makers

$11,748in general payments, 2019–2025

Across 443 payments — averaging $26.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Pfizer$1K
  • Lilly USA, LLC$984
  • Novo Nordisk$916
  • Boehringer Ingelheim$915
  • plus $5K from 41 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie79$1,747
AstraZeneca(2 entities)28$1,222
Pfizer59$1,065
Lilly USA, LLC43$984
Novo Nordisk30$916
Boehringer Ingelheim23$915
Astellas Pharma US Inc27$880
Corcept Therapeutics13$722
GSK26$530
Bayer14$509
Amgen24$401
Johnson & Johnson(2 entities)3$252
Merck10$184
Actelion Pharmaceuticals US, Inc.2$140
Teva Pharmaceuticals USA, Inc.1$132
Edwards Lifesciences2$124
Biohaven Pharmaceutical Holding Company Ltd.5$89
Harmony Biosciences LLC4$70
Idorsia Pharmaceuticals US Inc4$61
Medtronic3$52
Kowa Pharmaceuticals America, Inc.3$50
Sumitomo Pharma America, Inc.2$50
Nevro Corp.2$49
Abiomed2$48
Biohaven Pharmaceuticals, Inc.3$44
Sunovion Pharmaceuticals Inc.4$37
Takeda Pharmaceuticals U.S.A., Inc.2$37
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$36
Dexcom, Inc.2$36
Supernus Pharmaceuticals, Inc.1$32
Esperion Therapeutics, Inc.2$31
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$29
Abbott2$29
Vertex1$27
Mirum Pharmaceuticals, Inc.1$24
Verrica Pharmaceuticals Inc.1$22
Seqirus USA Inc1$20
Genentech USA, Inc.1$19
E.r. Squibb & Sons, L.L.C.1$17
Lucid Diagnostics Inc.1$17
Xeris Pharmaceuticals, Inc.1$17
Axonics, Inc.1$15
Forte Bio-pharma LLC1$15
Paratek Pharmaceuticals, Inc.1$14
Vanda Pharmaceuticals Inc.1$14
Eisai Inc.1$13
Alnylam Pharmaceuticals Inc.1$13

How this compares

$11,748 in reported general payments places this provider in the 95th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada →

Medicare billing

Part B allowed, 2024
$70,914
Medicare patients
233
Services billed
1,072

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Sparks

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →